RxDoctor Payments Data

Jessica Murphy

Nurse Practitioner · Central Falls, RINPI 1255901310

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 17 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Novo Nordisk accounts for 69.7% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2022 at $200 and has fallen 93.0% since, to $14 in 2025.

$439in general payments, 2019–2025

Across 17 payments — averaging $25.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$306
  • Exact Sciences$51
  • Bayer$20
  • Organon$19
  • Johnson & Johnson$17
  • E.r. Squibb & Sons, L.L.C.$14
  • plus $13 from 1 others

What the payments were for

  • Food & beverage$439100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$439 in reported general payments places this provider in the 85th percentile of 396 nurse practitioner providers in Rhode Island.

See all nurse practitioner providers in Rhode Island

Medicare billing

Part B allowed, 2024
$46,735
Medicare patients
256
Services billed
652

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban12$8,154
Atorvastatin Calcium72$1,340
Omeprazole58$919
Rosuvastatin Calcium41$790
Levothyroxine Sodium78$774
Albuterol Sulfate HfaAlbuterol Sulfate29$739
Duloxetine Hcl14$674
Fluticasone Propionate36$617
Lisinopril71$518
Trazodone Hcl27$476
Tamsulosin Hcl27$448
Simvastatin46$391
Amlodipine Besylate63$350
Losartan Potassium38$328
Sertraline Hcl44$310

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Central Falls

See the full list for Rhode Island

Where these figures come from

Is this you, or does something look wrong? →